kongre.net
Welcome to kongre.net
EA
CourseIn person

ESMO Advanced Course on Defining Endocrine Sensitivity & Optimising Treatment Strategies in HR+/HER2- mBC Patients 2026: Barcelona

Hosted by European Society for Medical Oncology

Let others know you'll be there. This does not register you for the event.

Welcome to kongre.net
Welcome to kongre.net

Key facts

ESMO Advanced Course on Defining Endocrine Sensitivity & Optimising Treatment Strategies in HR+/HER2- mBC Patients 2026: Barcelona is a course held 25 – 26 November 2026 in Barcelona, Spain, organised by European Society for Medical Oncology.

Dates:
25 – 26 November 2026
Format:
In person
Venue:
Barcelona, Spain
Subjects:
Oncology & Cancer Research
This advanced course focuses on defining endocrine sensitivity and optimising treatment strategies in HR+/HER2- metastatic breast cancer patients.

Conference theme

Defining Endocrine Sensitivity & Optimising Treatment Strategies in HR+/HER2- mBC Patients

Objectives

Evaluate clinical evidence supporting the use of targeted agents, endocrine therapy and antibody-drug conjugates in HR+/HER2 metastatic breast cancer. Recognise mechanisms of resistance and strategies to overcome them and to outline treatment sequencing. Assess the safety, toxicity, and quality of life implications of novel agents in HR+/HER2- metastatic breast cancer. Explore future directions in drug development.

Organising Committee

Giuseppe Curigliano - Chair, University of Milan and European Institute of Oncology, IRCCS Milan, Italy Barbara Pistilli - Chair, Gustave Roussy, Villejuif, France
Venue & travel Barcelona, SpainVenue detailsAbout the organiser European Society for Medical Oncology4 more events from this organiserOrganiser profileWho is going? See who is planning to attend and say you are goingSee who is going

Organiser and contact

Advertisement

Related events